Siena, Italy

Alessia Biolchi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alessia Biolchi

Introduction

Alessia Biolchi is a prominent inventor based in Siena, Italy. She has made significant strides in the field of vaccine development, particularly focusing on meningococcal vaccines. Her innovative approach aims to enhance the effectiveness of these vaccines by addressing the diversity of the proteins involved.

Latest Patents

Alessia holds a patent for her work on meningococcal vaccines. The patent emphasizes the improvement of these vaccines by incorporating multiple alleles or variants of fHbp. This strategy is designed to provide broader coverage of the diversity known for this protein. Additionally, her research suggests reducing the quantity of an outer membrane vesicle (OMV) component in each dose to optimize vaccine efficacy. She has 1 patent to her name.

Career Highlights

Alessia Biolchi is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. Her role at the company allows her to contribute to groundbreaking research and development in vaccine technology. Her work is crucial in the ongoing fight against meningococcal diseases.

Collaborations

Throughout her career, Alessia has collaborated with notable colleagues, including Brunella Brunelli and Marzia Monica Giuliani. These partnerships have fostered a collaborative environment that enhances the innovation process in vaccine development.

Conclusion

Alessia Biolchi's contributions to the field of vaccine development, particularly through her patent on meningococcal vaccines, highlight her role as an influential inventor. Her work continues to pave the way for advancements in public health and vaccine efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…